EDSA Total Utang marang Modal Edesa Biotech Corp
Anticipation of test results for a respiratory syndrome drug is creating powerful growth triggers for Edesa Biotech, Inc. (EDSA), while current quotes already price in operating losses. The price visualization assisting in the asset's base valuation demonstrates a total debt-to-equity ratio of 0.00, whereas global conflicts are hindering reagent logistics and international research. The company's bet on developing antibodies for immunity control guarantees exclusive rights, ensuring a steady profit stream.
Rincian analitis lan laporan data perusahaan Edesa Biotech Corp (EDSA)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Utang marang Ekuitas Edesa Biotech, Inc.|EDSA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Edesa Biotech, Inc.|EDSA - Gunggung utang perusahaan|Utang marang nilai buku Edesa Biotech|EDSA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Edesa Biotech
Analisis komprehensif perusahaan:EDSA - Edesa Biotech
This ratio determines the share of borrowed funds within the financing structure, measuring the volume of liabilities per unit of equity to assess credit risk. By analyzing the historical changes in the total debt-to-equity ratio, an investor can discern the financial stability of Edesa Biotech, Inc., which optimizes operating expenses through the robotization of immunological research, thereby reducing the need for capital expenditures on personnel.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|PVLA (Pieris Pharmaceuticals Inc) - Total Utang marang Modal|SVRA - Utang marang Modal|Total Utang marang Modal Rigel Pharmaceuticals|anaptysbio.com (ANAB) - Rasio Utang marang Ekuitas|Total Utang marang Modal ATXS (Astria Therapeutics, Inc.)|Utang marang Modal ENGN|RAPT (RAPT Therapeutics, Inc.) - Utang marang Ekuitas|Koefisien Total Utang marang Modal aerovatetx.com (JBIO)|Total Utang marang Modal ACRS (Aclaris Therapeutics)|KYTX - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Tiziana Life Sciences Ltd (TLSA)|CABA - Rasio Kabeh Utang marang Dana Pribadi|Ventyx Bio (VTYX) - Total Utang marang Modal|Theratechnologies, Inc (THTX) - Utang marang Ekuitas|AVTX: Total Utang marang Modal|Koefisien Total Utang marang Modal ELDN|Agenus Inc. - Utang marang Ekuitas|Utang marang Modal Climb Bio Inc. CLYM|Rasio Total Utang marang Ekuitas Zura Bio Limited (ZURA)|Utang Agregat marang Modal aTyr Pharmaceuticals ATYR|ADAG (Adagene Corp) - Total Utang marang Modal|IMA - Utang marang Modal|STTK (shattucklabs.com) - Total Utang marang Modal|Equillium (EQ) - Rasio Total Utang marang Ekuitas|CNTB - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Immunic Inc (IMUX)|Atara Biotherapeutics (ATRA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi inflarx.de (IFRX)|Total Utang marang Modal XFOR|Adicet Bio Inc. - Koefisien Total Utang marang Modal|Celularity Corp (CELU) - Utang marang Ekuitas|INMB - Rasio Utang marang Ekuitas|BRNS (Barinthus Biotherapeutics) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas kezarlifesciences.com|SABS: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal Akari Therapeutics PLC|Enlivex Therapeutics - Total Utang marang Modal|Utang marang Modal q32bio.com (QTTB)|GOVX - Total Utang marang Modal|ibioinc.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas CARM (Carisma Tx)|XTLB - Koefisien Total Utang marang Modal|BOLT: Total Utang marang Modal|HCWB (HCW Biologics) - Total Utang marang Modal|Utang marang Ekuitas Aptevo Therapeutics, Inc. APVO|Utang Agregat marang Ekuitas AIM ImmunoTech, Inc.|Aditxt (ADTX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi GRI Bio Inc (GRI)|Total Utang marang Modal XRTX (XORTX)|Vyome Therapeutics - Total Utang marang Modal|Utang marang Ekuitas Revelation Biosciences (REVB)|INDP: Rasio Kabeh Utang marang Dana Pribadi|SCNI (Scinai Immunotherapeutics Ltd.) - Utang marang Ekuitas|CalciMedica (CALI) - Rasio Total Utang marang Ekuitas|AFMD (Affimed NV) - Total Utang marang Modal|Total Utang marang Modal Allakos Therapeutics (ALLK)|HOOKIPA Pharma Inc. (HOOK) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi igmbio.com (IGMS)|Total Utang marang Modal ITOS|Ocean Biomedical Inc - Koefisien Total Utang marang Modal|TCBP: Utang marang Ekuitas|THRD: Rasio Total Utang marang Ekuitas